BIO-key International Inc. (NASDAQ:BKYI) Sees Large Decrease in Short Interest

BIO-key International Inc. (NASDAQ:BKYI) saw a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 158,340 shares, a decrease of 29.4% from the February 26th total of 224,434 shares. Based on an average daily volume of 583,713 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.5% of the company’s stock are short sold.

Institutional Investors Weigh In On BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC increased its stake in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors own 26.51% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Wednesday, January 21st. Wall Street Zen raised BIO-key International to a “sell” rating in a research report on Saturday, January 3rd. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

BIO-key International Price Performance

Shares of BIO-key International stock opened at $0.57 on Friday. The firm has a market cap of $6.22 million, a PE ratio of -0.55 and a beta of 0.41. The stock has a 50 day moving average of $0.63 and a 200 day moving average of $0.70. The company has a current ratio of 1.26, a quick ratio of 1.13 and a debt-to-equity ratio of 0.17. BIO-key International has a 12 month low of $0.51 and a 12 month high of $1.97.

About BIO-key International

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.